Tyche Wealth Partners LLC Bristol Myers Squibb CO Transaction History

Tyche Wealth Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$44.12 - $59.6 $31,016 - $41,898	-703 Reduced 11.12%	5,618 $260 Million
Q1 2025 Apr 23, 2025	BUY	$53.9 - $63.11 $31,908 - $37,361	592 Added 10.33%	6,321 $386 Million
Q4 2024 Jan 27, 2025	BUY	$51.92 - $59.94 $50,829 - $58,681	979 Added 20.61%	5,729 $324 Million
Q3 2024 Oct 25, 2024	SELL	$39.66 - $51.75 $39,303 - $51,284	-991 Reduced 17.26%	4,750 $246 Million
Q2 2024 Jul 18, 2024	SELL	$40.25 - $52.99 $36,305 - $47,796	-902 Reduced 13.58%	5,741 $238 Million

Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $7,388 - $8,377	-154 Reduced 2.27%	6,643 $360 Million
Q4 2023 Jan 30, 2024	BUY	$48.48 - $57.85 $329,518 - $393,206	6,797 New	6,797 $349 Million

2,692

1.58B

28M

28.4M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tyche Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Tyche Wealth Partners LLC with notifications on news.